Psychosocial treatment issues in the MTA: a reply to Greene and Ablon.
Discussed several of Greene and Ablon's (this issue) key points in their article about the Multimodal Treatment Study (MTA) of Children with Attention Deficit Hyperactivity Disorder (ADHD). In particular, the following issues are addressed: (a) whether the medication management and behavioral arms of the MTA individualized treatment to comparable degrees; (b) whether cognitive-behavioral interventions were incorporated to an adequate extent; (c) whether core ADHD symptoms were overemphasized relative to other functional domains, both as treatment targets and outcome measures; and (d) whether parent and teacher characteristics warranted more emphasis than they were given. These issues are discussed and an attempt is made to fit the MTA findings into the larger context of prior studies on treatment of childhood ADHD. A theme of this commentary is the concern that in the current age of biological emphasis in the field of ADHD research, social, family, and motivational processes may not get the attention they deserve.
Hoza
B
B
Department of Psychological Sciences, Purdue University, West Lafayette, IN 47907-1364, USA. blaze@psych.purdue.edu
D001289:Attention Deficit Disorder with Hyperactivity / Q000628:therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D011613:Psychotherapy / Q000379:methods*; D016896:Treatment Outcome
D000697:Central Nervous System Stimulants; D008774:Methylphenidate